AstraZeneca reported $1.84B in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alcon AG ALC:SW USD 24M 198M
Amgen AMGN:US USD 2.23B 436M
Artemis Alpha ATS:LN GBP -26696000 16.49M
AstraZeneca AZN:LN USD 1.84B 429M
AstraZeneca AZN:SS USD 1.84B 429M
Astrazeneca AZN:US USD 1.84B 429M
Bayer BAYN:GR EUR 3.94B 2.59B
Biogen BIIB:US USD 878.7M 6.6M
Bristol Myers Squibb BMY:US USD 2.32B 418M
Eli Lilly And LLY:US USD 2.11B 169.2M
Fresenius FRE:GR EUR 1.05B 207M
Fresenius Medical Care FME:GR EUR 445M 136.5M
Galapagos GLPG:NA EUR -159164000 121.59M
Genmab GEN:DC DKK 2.66B 734M
Gilead Sciences GILD:US USD 2.27B 565M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Hikma Pharmaceutical HIK:LN USD 302M 46M
Lonza Group LONN:SW CHF 699M 1000K
Merck MRK:GR EUR 1.16B 189M
Merk MRK:US USD 4.81B 725M
Novartis NOVN:VX USD 3.1B 228M
Orion ORNBV:FH EUR 40.7M 204.7M
Pfizer PFE:US USD 5.81B 3.89B
Philips PHIA:NA EUR 548M 443M
Recordati REC:IM EUR 129.41M 6.95M
Regeneron Pharmaceuticals REGN:US USD 1.18B 46.9M
Roche Holding ROG:VX 8.49B 3.05B